BG101867A - Бензотиазиндиоксиди като антагонисти на ендотелин - Google Patents

Бензотиазиндиоксиди като антагонисти на ендотелин

Info

Publication number
BG101867A
BG101867A BG101867A BG10186797A BG101867A BG 101867 A BG101867 A BG 101867A BG 101867 A BG101867 A BG 101867A BG 10186797 A BG10186797 A BG 10186797A BG 101867 A BG101867 A BG 101867A
Authority
BG
Bulgaria
Prior art keywords
benzothiazenedioxides
preparation
endothelin antagonists
pulmanaryhypertension
newintermediate
Prior art date
Application number
BG101867A
Other languages
English (en)
Other versions
BG62613B1 (bg
Inventor
Kent Berryman
Amy Bunker
Annette Doherty
Jeremy Edmunds
Original Assignee
Warner-Lambert Company Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner-Lambert Company Llc filed Critical Warner-Lambert Company Llc
Publication of BG101867A publication Critical patent/BG101867A/bg
Publication of BG62613B1 publication Critical patent/BG62613B1/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/02—1,2-Thiazines; Hydrogenated 1,2-thiazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Dental Preparations (AREA)
  • Polyesters Or Polycarbonates (AREA)

Abstract

Изобретението се отнася до нови бензотиазиндиоксиди, до нови междинни съединения, които се използват за тяхното получаване, до методи за получаванетоим и до фармацевтични състави, които ги съдържат.Те намират приложение при лечението на повишени нива ендотелин, есенциална реноваскуларна злокачествена и белодробна хипертензия, мозъчен инфаркт, исхемия на мозъка, застойна сърдечна недостатъчност исубарахноидален кръвоизлив.
BG101867A 1995-02-21 1997-09-01 Бензотиазиндиоксиди като антагонисти на ендотелин BG62613B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/393,143 US5599811A (en) 1995-02-21 1995-02-21 Benzothiazine dioxides as endothelin antagonists
PCT/US1996/001093 WO1996026195A1 (en) 1995-02-21 1996-01-26 Benzothiazine dioxides as endothelin antagonists

Publications (2)

Publication Number Publication Date
BG101867A true BG101867A (bg) 1998-10-30
BG62613B1 BG62613B1 (bg) 2000-03-31

Family

ID=23553452

Family Applications (1)

Application Number Title Priority Date Filing Date
BG101867A BG62613B1 (bg) 1995-02-21 1997-09-01 Бензотиазиндиоксиди като антагонисти на ендотелин

Country Status (27)

Country Link
US (1) US5599811A (bg)
EP (1) EP0811001B1 (bg)
JP (1) JPH11501013A (bg)
KR (1) KR19980702358A (bg)
CN (1) CN1071327C (bg)
AT (1) ATE207911T1 (bg)
AU (1) AU720036B2 (bg)
BG (1) BG62613B1 (bg)
CA (1) CA2211027A1 (bg)
CZ (1) CZ294412B6 (bg)
DE (1) DE69616515T2 (bg)
DK (1) DK0811001T3 (bg)
EE (1) EE03564B1 (bg)
ES (1) ES2167544T3 (bg)
FI (1) FI973380A (bg)
GE (1) GEP20001969B (bg)
HU (1) HUP9800273A3 (bg)
NO (1) NO308897B1 (bg)
NZ (1) NZ302116A (bg)
PL (1) PL321866A1 (bg)
PT (1) PT811001E (bg)
RO (1) RO116898B1 (bg)
RU (1) RU2164225C2 (bg)
SK (1) SK284275B6 (bg)
UA (1) UA47424C2 (bg)
WO (1) WO1996026195A1 (bg)
ZA (1) ZA961342B (bg)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5962490A (en) 1987-09-25 1999-10-05 Texas Biotechnology Corporation Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US6541498B2 (en) 1993-05-20 2003-04-01 Texas Biotechnology Benzenesulfonamides and the use thereof to modulate the activity of endothelin
US6613804B2 (en) 1993-05-20 2003-09-02 Encysive Pharmaceuticals, Inc. Biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
US6376523B1 (en) 1994-05-20 2002-04-23 Texas Biotechnology Corporation Benzenesulfonamides and the use thereof to modulate the activity of endothelin
US6342610B2 (en) 1993-05-20 2002-01-29 Texas Biotechnology Corp. N-aryl thienyl-, furyl-, and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US6030991A (en) * 1993-05-20 2000-02-29 Texas Biotechnology Corp. Benzenesulfonamides and the use thereof to modulate the activity of endothelin
US5945448A (en) * 1995-06-02 1999-08-31 Shionogi & Co., Ltd. Brain edema inhibitor
US5804585A (en) * 1996-04-15 1998-09-08 Texas Biotechnology Corporation Thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelin
US6432994B1 (en) 1997-04-28 2002-08-13 Texas Biotechnology Corporation Sulfonamides for treatment of endothelin-mediated disorders
US5783705A (en) * 1997-04-28 1998-07-21 Texas Biotechnology Corporation Process of preparing alkali metal salys of hydrophobic sulfonamides
CA2295239A1 (en) 1997-06-27 1999-01-07 Fujisawa Pharmaceutical Co., Ltd. Sulfonamide compounds and medicinal use thereof
PL338983A1 (en) * 1997-09-05 2000-12-04 Warner Lambert Co Some dioxides of benzothiazine as antagonists of endothelin and methods of obtaining them
GB2337048B (en) * 1998-05-05 2000-06-28 Warner Lambert Co 2,1,3-Benzothiadiazole containing endothelin antagonists
WO2001091736A2 (en) * 2000-05-31 2001-12-06 Warner-Lambert Company Combinations of an endothelin receptor antagonist and an antiepileptic compound having pain alleviating properties or analgesic
US20020115661A1 (en) * 2000-12-07 2002-08-22 Keller Laurence Harvey Method for treating chronic obstructive pulmonary disease
BRPI0709950A2 (pt) * 2006-04-13 2011-08-02 Actelion Pharmaceuticals Ltd uso de bosentan na preparação de um medicamento para o tratamento de fibrose pulmonar idiopática em estágio precoce e uso de antagonista do receptor endotelin
FR2942797B1 (fr) * 2009-03-03 2011-04-29 Pf Medicament Derives de benzothiazines, leur preparation et leur application a titre de medicaments
US10865201B2 (en) * 2016-09-12 2020-12-15 Valo Health, Inc. Bicyclic compounds useful as GPR120 modulators
CN114671827B (zh) * 2020-12-24 2024-09-20 杭州百新生物医药科技有限公司 邻苯甲酰磺酰亚胺类衍生物及其应用
CN112521384B (zh) * 2021-01-13 2021-11-02 湖北大学 溶剂热一锅法合成苯并噻嗪并环戊二烯衍生物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3237473A1 (de) * 1982-10-09 1984-04-12 Dr. Karl Thomae Gmbh, 7950 Biberach Neue 4-hydroxy-2h-1,2-benzothiazin-3-carboxamid-1,1-dioxide, verfahren zu ihrer herstellung, ihre verwendung und diese verbindungen enthaltende arzneimittel
CA2032559C (en) * 1989-12-28 2001-11-06 Kiyofumi Ishikawa Endothelin antagonistic cyclic pentapeptides
JPH0441483A (ja) * 1990-06-07 1992-02-12 Tanabe Seiyaku Co Ltd ベンゾチアジン誘導体及びその製法
RU2125980C1 (ru) * 1991-11-05 1999-02-10 Смитклайн Бичам Корпорейшн Антагонисты эндотелиновых рецепторов, фармкомпозиция, способ их получения, способ подавления эндотелиновых рецепторов
US5389620A (en) * 1993-08-18 1995-02-14 Banyu Pharmaceutical Co., Ltd. Endothelin antagonistic heteroaromatic ring-fused cyclopentene derivatives

Also Published As

Publication number Publication date
UA47424C2 (uk) 2002-07-15
ZA961342B (en) 1996-08-26
HUP9800273A3 (en) 1999-09-28
DE69616515T2 (de) 2002-05-16
WO1996026195A1 (en) 1996-08-29
CZ294412B6 (cs) 2004-12-15
NO308897B1 (no) 2000-11-13
KR19980702358A (ko) 1998-07-15
AU720036B2 (en) 2000-05-18
NO973822D0 (no) 1997-08-20
ATE207911T1 (de) 2001-11-15
RU2164225C2 (ru) 2001-03-20
CN1071327C (zh) 2001-09-19
CZ260797A3 (cs) 1998-06-17
ES2167544T3 (es) 2002-05-16
GEP20001969B (en) 2000-03-05
FI973380A (fi) 1997-08-20
DK0811001T3 (da) 2002-02-18
MX9706024A (es) 1997-11-29
CA2211027A1 (en) 1996-08-29
AU4770396A (en) 1996-09-11
NZ302116A (en) 1998-06-26
NO973822L (no) 1997-08-21
SK114697A3 (en) 1998-08-05
PT811001E (pt) 2002-04-29
EE03564B1 (et) 2001-12-17
HUP9800273A2 (hu) 1999-07-28
CN1180351A (zh) 1998-04-29
EE9700147A (et) 1997-12-15
RO116898B1 (ro) 2001-07-30
US5599811A (en) 1997-02-04
DE69616515D1 (de) 2001-12-06
JPH11501013A (ja) 1999-01-26
SK284275B6 (sk) 2004-12-01
EP0811001A1 (en) 1997-12-10
EP0811001B1 (en) 2001-10-31
BG62613B1 (bg) 2000-03-31
PL321866A1 (en) 1997-12-22
FI973380A0 (fi) 1997-08-18

Similar Documents

Publication Publication Date Title
BG101867A (bg) Бензотиазиндиоксиди като антагонисти на ендотелин
HK1002031A1 (en) Compounds having antihypertensive and anti-ischemic properties
IL105511A (en) 2,4-dioxoimidazolidine derivatives their preparation and pharmaceutical compositions containing them
ES2136037A1 (es) Inhibidores de sulfamida-metaloproteasa
MY120976A (en) 2-amino-6-(2-substituted-4-phenoxy)- substituted- pyridines
IL106821A0 (en) Imidazolidine derivatives,their preparation and pharmaceutical compositions containing them
NZ520624A (en) 1,2,3,4-tetrahydroisoquinoline derivatives
IL114599A0 (en) Substituted pyrimidine compounds their preparation and pharmaceutical compositions containing them
BG103489A (bg) Зипрасидонови препарати
ATE429210T1 (de) Orale flüssige zusammensetzungen
BG103286A (bg) Състави и методи за обогатяване на руда
HK1041449B (zh) 可在體內減少α2-抗纖溶酶的化合物在製備用於治療局部缺血性中風的組合物中的用途
BG105256A (bg) Мускаринови агонисти и антагонисти
NO20001556L (no) Kontrastmidler for infarkt- og nekroseavbildning
IL117209A (en) 1-aryl-2-acylamino-ethane compounds and pharmaceutical compositions containing them
MY120550A (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, processes for preparing them and their use as pharmaceutical compositions.
AU6415994A (en) Substituted caprolactams and derivatives thereof useful for treatment of hiv disease
BG103260A (bg) Използване на 1-хидрокси-2-пиридони за лечение насебореен дерматит
MY107354A (en) Substituted cyclohexenes as central nervous system agents
IL104485A0 (en) Benzimidazoles,their preparation and pharmaceutical compositions containing them
BG102229A (bg) Антагонисти на ендотелинови рецептори
MX9706927A (es) Antagonistas biciclicos de taquicininas, preparacion de los mismos y su uso en composiciones farmaceuticas.
MY117392A (en) Monocyclic compounds with four bifunctional residues having nk-2 antagonist action
MY107258A (en) 1-methoxypyrimidinyl-n-nitrophenyl-1h-1,2,4-triazole-3- sulphonamides, processes for their preparation and their use as herbicides.
MX9805015A (es) INHIBIDORES DE LA ENZIMA QUE CONVIERTE LA INTERLEUCINA-1 beta.